seed
Stage
1
Investors
About
Tulavi develops a proprietary, fully absorbable hydrogel platform designed to reduce symptomatic neuroma formation and improve outcomes in peripheral nerve surgeries.
Explore Tulavi's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.